J. B. Chemicals & Pharmaceuticals Limited (JB Chemicals) has announced a major restructuring through its amalgamation with Torrent Pharmaceuticals Limited (Torrent Pharma) .
The Hon’ble NCLT, Ahmedabad Bench has approved the Scheme of Amalgamation , under which J. B. Chemicals & Pharmaceuticals Limited is being merged into Torrent Pharmaceuticals Limited .
Here’s what it means for shareholders
JB Chemicals shareholders will now receive Torrent Pharma shares in exchange for their JB Chemicals shares.
Record Date: July 17, 2026
Exchange Ratio:
51 fully paid-up equity shares of Torrent Pharmaceuticals Limited (Face Value ₹5 each)
for every
100 fully paid-up equity shares of J. B. Chemicals & Pharmaceuticals Limited (Face Value Re.1 each) .
Key Highlights
- Approval Authority: Hon’ble NCLT, Ahmedabad Bench
- NCLT Order Date: July 6, 2026
- Record Date: July 17, 2026
Post-Merger Status
- J. B. Chemicals & Pharmaceuticals Limited will be amalgamated with Torrent Pharmaceuticals Limited .
- Torrent Pharmaceuticals Limited will continue as the listed company.
What changes for investors
- Shareholders of JB Chemicals whose names appear on the Record Date will receive Torrent Pharma shares in the approved exchange ratio.
- Upon implementation of the scheme, the existing equity shares of JB Chemicals will be replaced by Torrent Pharma shares in accordance with the approved arrangement.
This merger is aimed at:
- Strengthening Torrent Pharma’s presence in the Indian pharmaceutical market,
- Expanding its branded formulations and specialty product portfolio,
- Achieving operational and business synergies through integration, and
- Creating long-term value for shareholders through a larger and more diversified pharmaceutical business.